What is Advanced Oxygen Technologies I's earnings per share (EPS)?

Advanced Oxygen Technologies I (AOXY) reported diluted earnings per share of $0.00 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Advanced Oxygen Technologies I Financials

AOXY

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE June

This page shows Advanced Oxygen Technologies I (AOXY) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 49/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Advanced Oxygen Technologies I has an operating margin of 31.7%, meaning the company retains $32 of operating profit per $100 of revenue. This strong profitability earns a score of 93/100, reflecting efficient cost management and pricing power. This is down from 33.9% the prior year.

Growth

Advanced Oxygen Technologies I's revenue grew a modest 2.0% year-over-year to $43K. This slow but positive growth earns a score of 37/100.

Leverage

100

Advanced Oxygen Technologies I carries a low D/E ratio of 0.00, meaning only $0.00 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Advanced Oxygen Technologies I's current ratio of 0.39 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 2/100, which could limit financial flexibility.

Returns

Advanced Oxygen Technologies I generates a 1.0% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 13/100. This is down from 1.6% the prior year.

Altman Z-Score Distress

-41.45

Advanced Oxygen Technologies I scores -41.45, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($231K) relative to total liabilities ($277K). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Piotroski F-Score Neutral

5/9

Advanced Oxygen Technologies I passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

9.77x

For every $1 of reported earnings, Advanced Oxygen Technologies I generates $9.77 in operating cash flow ($40K OCF vs $4K net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$43K

YoY+2.0%

5Y CAGR+0.1%

10Y CAGR+1.2%

Advanced Oxygen Technologies I generated $43K in revenue in fiscal year 2025. This represents an increase of 2.0% from the prior year.

EBITDA

N/A

Net Income

$4K

YoY-25.6%

10Y CAGR-13.8%

Advanced Oxygen Technologies I reported $4K in net income in fiscal year 2025. This represents a decrease of 25.6% from the prior year.

EPS (Diluted)

$0.00

Advanced Oxygen Technologies I earned $0.00 per diluted share (EPS) in fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$57K

YoY-39.4%

5Y CAGR+5.6%

10Y CAGR-1.7%

Advanced Oxygen Technologies I held $57K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

YoY+0.0%

5Y CAGR+0.0%

10Y CAGR+3.7%

Advanced Oxygen Technologies I had 3M shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

31.7%

YoY-2.2pp

5Y CAGR+244.9pp

Advanced Oxygen Technologies I's operating margin was 31.7% in fiscal year 2025, reflecting core business profitability. This is down 2.2 percentage points from the prior year.

Net Margin

9.5%

YoY-3.6pp

5Y CAGR+248.4pp

10Y CAGR-37.6pp

Advanced Oxygen Technologies I's net profit margin was 9.5% in fiscal year 2025, showing the share of revenue converted to profit. This is down 3.6 percentage points from the prior year.

Return on Equity

1.0%

YoY-0.6pp

5Y CAGR+34.7pp

10Y CAGR-6.0pp

Advanced Oxygen Technologies I's ROE was 1.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 0.6 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

AOXY Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$43K+2.0%	$43K+8.0%	$39K-0.3%	$40K-4.6%	$41K-4.0%	$43K
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$7K+0.5%	$7K-5.4%	$7K-4.6%	$7K-15.2%	$9K+31.8%	$7K
Operating Income	$14K-4.7%	$14K+29.0%	$11K	N/A	$17K+118.1%	-$92K
Interest Expense	N/A	$296-61.6%	$771-60.3%	$2K-27.7%	$3K-18.4%	$3K
Income Tax	$10K+8.7%	$9K+12.5%	$8K+1.4%	$8K-2.4%	$8K+5.6%	$8K
Net Income	$4K-25.6%	$6K+145.0%	$2K-96.0%	$57K+891.9%	$6K+105.6%	-$103K
EPS (Diluted)	$0.00	$0.00	$0.00-100.0%	$0.02	$0.00+100.0%	$-0.03

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$12K-0.5%	$12K+35.1%	$9K-17.6%	$11K-20.1%	$13K+21.8%	$11K+2.0%	$11K-0.9%	$11K
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$2K+58.5%	$1K-20.2%	$2K+9.4%	$1K-2.0%	$2K-25.9%	$2K+21.7%	$2K+21.5%	$1K
Operating Income	$5K+631.7%	-$973-131.4%	$3K-39.3%	$5K-34.1%	$8K+456.2%	-$2K-143.5%	$5K-7.3%	$5K
Interest Expense	N/A	N/A	N/A	N/A	$352	$0+100.0%	-$145	$0
Income Tax	$3K+2.1%	$2K+0.6%	$2K+7.7%	$2K-22.5%	$3K+27.9%	$2K+0.8%	$2K-20.5%	$3K
Net Income	$3K+176.9%	-$3K-635.8%	$643-77.2%	$3K-45.3%	$5K+215.1%	-$4K-264.8%	$3K+7.8%	$3K
EPS (Diluted)	$0.00	$0.00	N/A	$0.00	$0.00	$0.00	N/A	$0.00

AOXY Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$693K+2.6%	$675K-3.2%	$698K+5.4%	$662K-5.0%	$697K+6.6%	$654K
Current Assets	$58K-38.8%	$96K-9.8%	$106K+11.2%	$95K+86.0%	$51K+14.4%	$45K
Cash & Equivalents	$57K-39.4%	$94K-9.9%	$105K+11.3%	$94K+88.5%	$50K+14.6%	$44K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$277K-16.7%	$333K-3.9%	$347K+1.3%	$343K-2.5%	$351K+1.0%	$348K
Current Liabilities	$150K-27.1%	$206K-6.2%	$220K+5.5%	$209K+5.8%	$197K-35.1%	$304K
Long-Term Debt	$0-100.0%	$127K-5.2%	$134K-11.2%	$151K-13.0%	$173K-8.0%	$189K
Total Equity	$416K+21.5%	$342K-2.5%	$351K+9.7%	$320K-7.6%	$346K+13.1%	$306K
Retained Earnings	-$20.8M0.0%	-$20.8M0.0%	-$20.8M0.0%	-$20.8M+0.3%	-$20.8M0.0%	-$20.8M

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$670K-1.6%	$681K-1.7%	$693K+7.5%	$645K+2.5%	$629K-9.4%	$694K+2.8%	$675K-2.2%	$691K
Current Assets	$35K-24.6%	$47K-20.1%	$58K-0.7%	$59K-10.5%	$66K-26.3%	$89K-6.8%	$96K-10.1%	$106K
Cash & Equivalents	$34K-25.4%	$46K-20.4%	$57K-0.8%	$58K-10.6%	$65K-26.6%	$88K-6.9%	$94K-10.2%	$105K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$254K-5.3%	$268K-3.3%	$277K-4.8%	$291K-5.1%	$307K-5.7%	$326K-2.3%	$333K-3.6%	$346K
Current Liabilities	$254K-5.3%	$268K+78.4%	$150K-48.4%	$291K-5.1%	$307K-5.7%	$326K+57.9%	$206K-40.4%	$346K
Long-Term Debt	$0	$0	$0	$0-100.0%	$127K0.0%	$127K0.0%	$127K0.0%	$127K
Total Equity	$416K+0.8%	$413K-0.7%	$416K+17.7%	$353K+9.7%	$322K-12.6%	$368K+7.7%	$342K-0.8%	$345K
Retained Earnings	-$20.8M0.0%	-$20.8M0.0%	-$20.8M0.0%	-$20.8M0.0%	-$20.8M0.0%	-$20.8M0.0%	-$20.8M0.0%	-$20.8M

AOXY Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$40K-10.4%	$45K+27.5%	$35K-60.5%	$90K+137.6%	$38K+3.8%	$36K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	-$125
Financing Cash Flow	-$90K-69.5%	-$53K-81.7%	-$29K+12.4%	-$33K+0.7%	-$34K+5.3%	-$35K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	$15K+40.1%	$10K-24.5%	$14K+41.5%	$10K+34.4%	$7K-24.0%	$10K-30.5%	$14K+49.9%	$9K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	-$26K-18.4%	-$22K+13.9%	-$26K-36.3%	-$19K+24.6%	-$25K-25.6%	-$20K+14.4%	-$23K-153.0%	-$9K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

AOXY Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	31.7%-2.2pp	33.9%+5.5pp	28.4%	N/A	40.3%+253.5pp	-213.2%
Net Margin	9.5%-3.6pp	13.1%+7.3pp	5.8%-138.5pp	144.2%+130.4pp	13.9%+252.8pp	-238.9%
Return on Equity	1.0%-0.6pp	1.6%+1.0pp	0.7%-17.2pp	17.8%+16.2pp	1.7%+35.4pp	-33.7%
Return on Assets	0.6%-0.2pp	0.8%+0.5pp	0.3%-8.3pp	8.6%+7.8pp	0.8%+16.6pp	-15.8%
Current Ratio	0.39-0.1	0.46-0.0	0.48+0.0	0.46+0.2	0.26+0.1	0.15
Debt-to-Equity	0.00-0.4	0.37-0.0	0.38-0.1	0.47-0.0	0.50-0.1	0.62
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	44.1%+52.4pp	-8.3%-43.8pp	35.5%-12.7pp	48.2%-10.2pp	58.4%+78.4pp	-20.0%-66.8pp	46.8%-3.3pp	50.1%
Net Margin	22.6%+51.8pp	-29.2%-36.6pp	7.4%-19.3pp	26.6%-12.3pp	38.9%+80.0pp	-41.1%-66.6pp	25.4%+2.0pp	23.4%
Return on Equity	0.6%+1.5pp	-0.8%-1.0pp	0.1%-0.7pp	0.8%-0.8pp	1.6%+2.8pp	-1.2%-2.0pp	0.8%+0.1pp	0.7%
Return on Assets	0.4%+0.9pp	-0.5%-0.6pp	0.1%-0.4pp	0.4%-0.4pp	0.8%+1.5pp	-0.6%-1.0pp	0.4%+0.0pp	0.4%
Current Ratio	0.14-0.0	0.17-0.2	0.39+0.2	0.20-0.0	0.21-0.1	0.27-0.2	0.46+0.2	0.31
Debt-to-Equity	0.000.0	0.000.0	0.000.0	0.00-0.4	0.39+0.0	0.34-0.0	0.370.0	0.37
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: The current ratio is below 1.0 (0.39), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

What is Advanced Oxygen Technologies I's annual revenue?

Advanced Oxygen Technologies I (AOXY) reported $43K in total revenue for fiscal year 2025. This represents a 2.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Advanced Oxygen Technologies I's revenue growing?

Advanced Oxygen Technologies I (AOXY) revenue grew by 2% year-over-year, from $43K to $43K in fiscal year 2025.

Is Advanced Oxygen Technologies I profitable?

Yes, Advanced Oxygen Technologies I (AOXY) reported a net income of $4K in fiscal year 2025, with a net profit margin of 9.5%.

How much debt does Advanced Oxygen Technologies I have?

As of fiscal year 2025, Advanced Oxygen Technologies I (AOXY) had $57K in cash and equivalents against $0 in long-term debt.

What is Advanced Oxygen Technologies I's operating margin?

Advanced Oxygen Technologies I (AOXY) had an operating margin of 31.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Advanced Oxygen Technologies I's net profit margin?

Advanced Oxygen Technologies I (AOXY) had a net profit margin of 9.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Advanced Oxygen Technologies I's return on equity (ROE)?

Advanced Oxygen Technologies I (AOXY) has a return on equity of 1.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Advanced Oxygen Technologies I's operating cash flow?

Advanced Oxygen Technologies I (AOXY) generated $40K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Advanced Oxygen Technologies I's total assets?

Advanced Oxygen Technologies I (AOXY) had $693K in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Advanced Oxygen Technologies I have outstanding?

Advanced Oxygen Technologies I (AOXY) had 3M shares outstanding as of fiscal year 2025.

What is Advanced Oxygen Technologies I's current ratio?

Advanced Oxygen Technologies I (AOXY) had a current ratio of 0.39 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Advanced Oxygen Technologies I's debt-to-equity ratio?

Advanced Oxygen Technologies I (AOXY) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Advanced Oxygen Technologies I's return on assets (ROA)?

Advanced Oxygen Technologies I (AOXY) had a return on assets of 0.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Advanced Oxygen Technologies I's Altman Z-Score?

Advanced Oxygen Technologies I (AOXY) has an Altman Z-Score of -41.45, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Advanced Oxygen Technologies I's Piotroski F-Score?

Advanced Oxygen Technologies I (AOXY) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Advanced Oxygen Technologies I's earnings high quality?

Advanced Oxygen Technologies I (AOXY) has an earnings quality ratio of 9.77x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Advanced Oxygen Technologies I?

Advanced Oxygen Technologies I (AOXY) scores 49 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.